tiprankstipranks
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI

Brainstorm Cell Therapeutics (BCLI) Technical Analysis

509 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Brainstorm Cell Therapeutics’s (BCLI) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Brainstorm Cell Therapeutics is a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 20-Day exponential moving average is 0.39, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.346, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 50-Day exponential moving average is 0.42, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.346, making it a Sell.

Brainstorm Cell Therapeutics (BCLI) Pivot Points

Jul 22, 2024, 09:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.34
0.36
0.37
0.38
0.40
0.41
0.42
Fibonacci
0.36
0.37
0.37
0.38
0.39
0.40
0.41
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Brainstorm Cell Therapeutics (BCLI) Moving Averages

Jul 22, 2024, 09:25 AM
Period
Simple
Exponential
MA5
0.39Sell
0.38Sell
MA10
0.38Sell
0.38Sell
MA20
0.37Sell
0.39Sell
MA50
0.44Sell
0.42Sell
MA100
0.46Sell
0.45Sell
MA200
0.36Sell
0.53Sell
Brainstorm Cell Therapeutics’s (BCLI) 10-Day exponential moving average is 0.38, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.346, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 100-Day exponential moving average is 0.45, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.346, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.346 and Brainstorm Cell Therapeutics’s (BCLI) 50-day simple moving average is 0.44, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.346 and Brainstorm Cell Therapeutics’s (BCLI) 100-day simple moving average is 0.46, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.346 and Brainstorm Cell Therapeutics’s (BCLI) 200-day simple moving average is 0.36, creating a Sell signal.

Brainstorm Cell Therapeutics (BCLI) Technical Indicators

Jul 22, 2024, 09:25 AM
Name
Value
Implied Action
RSI (14)
40.88
Neutral
STOCH (9,6)
37.51
Neutral
STOCHRSI (14)
43.33
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
15.36
Buy
Williams %R
-80.00
Buy
CCI (14)
-53.59
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
43.78
Neutral
ROC
2.94
Buy
Brainstorm Cell Therapeutics’s (BCLI) Relative Strength Index (RSI) is 40.88, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Trend Strength Indicator (ADX) is 15.36, creating a Buy signal.
Brainstorm Cell Therapeutics’s (BCLI) Commodity Channel Index (CCI) is -53.59, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Price Rate of Change (ROC) is 2.94, creating a Buy signal.

FAQ

Is BCLI a Buy, Hold, or Sell?
Based on BCLI’s technical indicators, BCLI is a Strong Sell.
    What is BCLI’s RSI (14)?
    BCLI’s RSI (14) is 40.88, which suggests BCLI is a Neutral.
      What is BCLI’s MACD?
      BCLI’s MACD is -0.01, which suggests BCLI is a Sell.
        What is BCLI’s 5-day moving average?
        BCLI’s 5-day moving average is 0.39, which suggests BCLI is a Sell.
          What is BCLI’s 20-day moving average?
          BCLI 20-day moving average is 0.37, which suggests BCLI is a Sell.
            What is BCLI’s 50-day moving average?
            BCLI’s 50-day moving average is 0.44, which suggests BCLI is a Sell.
              What is BCLI’s 200-day moving average?
              BCLI’s 200-day moving average is 0.36, which suggests BCLI is a Sell.
                What is BCLI’s Williams % R (14)?
                BCLI’s Williams % R (14) is -80.00, which suggests BCLI is a Buy.
                  What is BCLI’s CCI (14)?
                  BCLI’s CCI (14) is -53.59, which suggests BCLI is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis